Ampio Pharmaceuticals
AMPE
#11136
Rank
โ‚น19.79 M
Marketcap
โ‚น17.43
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Ampio Pharmaceuticals (AMPE)

Revenue in 2023 (TTM): N/A

a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ampio Pharmaceuticals from 2009 to 2023

Annual revenue

Year Revenue Change
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A-100%
2015 โ‚น31.18 M540.72%
2014 โ‚น4.86 M57.55%
2013 โ‚น3.08 M12.83%
2012 โ‚น2.73 M176.01%
2011 โ‚น0.99 M
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚น9.175 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น6.028 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น4.297 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น1.420 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Rigel Pharmaceuticals
RIGL
โ‚น28.54 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
โ‚น9.55 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚น20.37 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA